{"SPADE_N_15341": {"Sequence Information": {"Peptide Name": "Trikoningin KB-I", "Sequence": "XGVXGGVXGI", "Sequence Length": 10, "Biological Activity": ["Antiparasitic", "Anticancer"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Trichoderma koningii", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Leveraging Peptaibol Biosynthetic Promiscuity for Next-Generation Antiplasmodial Therapeutics.", "Pubmed ID": "33565879", "Reference": "J Nat Prod. 2021;84:503-517", "Author": "Lee JW, Collins JE, Wendt KL, Chakrabarti D, Cichewicz RH", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33565879"}], "SPADE ID": "SPADE_N_15341", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_08816", "Similarity": 1.0, "Sequence": "GVGIGFIMMGVVGYAVKLVHIPIRYLIV"}, {"SPADE_ID": "SPADE_N_15500", "Similarity": 1.0, "Sequence": "VGISVGL"}, {"SPADE_ID": "SPADE_N_01520", "Similarity": 0.8571428571428571, "Sequence": "SLRGFLKGVGTALAGVGKVVADQFDKLLQAGQ"}], "Hemolytic Activity": "", "Target Organism": "Plasmodium falciparum Dd2(EC50=0.91±0.05µM),Human hepatocellular carcinoma HepG2(EC50=10.73±1.47µM)"}}}